News

Covid-19 (Sars-CoV-2) Test

 Sept. 22, 2020

DetectaChem Smartphone-Based COVID-19 Test Advances Through NIH RADx (Rapid Acceleration of Diagnostics) Program

DetectaChem, the global leader in innovative portable threat detection solutions used extensively by the U.S. Department of Defense and Homeland Security, today announces that their MD-Bio (MobileDetect Bio) BCP19 Test Pouch for COVID-19 detection successfully passed the initial Deep Dive phase in July 2020 and is currently advancing quickly through Phase 1 of the NIH (National Institutes of Health) RADxSM (Rapid Acceleration of Diagnostics) Tech initiative.
 PRNewswire

Detectachem Receives FDA EUA Authorization for MobileDetect Bio, Covid-19 (SARS-CoV-2) Smartphone Test Kit

View the BCC19 FDA EUA Authorization

COVID-19 ( SARS-CoV-2 ) Detection Kit
Sept. 3, 2020
DetectaChem Receives FDA EUA Authorization for Mobile COVID-19 Detection Technology
DetectaChem, the global leader in innovative portable threat detection technologies used daily by U.S. Homeland Security, Department of Defense and first responder agencies around the world, today announces their MobileDetect Bio (MD-Bio) BCC19 COVID-19 test kit has received FDA (Food and Drug Administration) EUA (Emergency Use Authorization).
PRNewswire

 

Sept. 3, 2020
DetectaChem gets FDA EUA status for mobile Covid-19 detection technology
The MobileDetect BioBCC19 Covid-19 test applies portable laboratory-grade diagnostic technology that holds the capacity to run up to 96 tests per device in 30 minutes

 

Sept. 3, 2020
Detectachem wins EUA for rapid COVID-19 test kit
Detectachem Inc. has scored an emergency use authorization (EUA) from the U.S. FDA to market a new molecular RNA test kit for SARS-CoV-2 that provides color-coded results in about 30 minutes.
 
BioWorld
 
Sept. 3, 2020
FDA Issues EUAs for Detectachem, Optolane Technologies Coronavirus Tests, Color Collection Kit
NEW YORK — The US Food and Drug Administration on Tuesday granted separate Emergency Use Authorizations for molecular SARS-CoV-2 tests developed by Detectachem and Optolane Technologies, as well as a nasal swab self-collection kit from Color Genomics.
GenomeWeb

 

Sept. 3, 2020
FDA Issues EUAs for Detectachem, Optolane Technologies Coronavirus Tests, Color Collection Kit
Detectachem’s MobileDetect Bio BCC19 Test Kit uses reverse transcription loop-mediated isothermal nucleic acid amplification to detect the N and E genes of SARS-CoV-2 in nasopharyngeal, anterior nasal, mid-turbinate nasal, and oropharyngeal swab specimens.
360 Dx

 

Sept. 3, 2020
FDA authorizes mobile COVID-19 test kit
The FDA has issued emergency use authorization (EUA) for a mobile COVID-19 test kit developed by handheld detection system maker DetectaChem.
+MASSDEVICE

 

MobileDetectBIO Mobile Experience
April 1, 2020

DetectaChem Creates First Mass-Market Smartphone COVID-19 Test Kit

GlobeNewsWire